|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-4-24
|
|
pubmed:abstractText |
Bacillus Calmette-Guerin (BCG) immunotherapy has been widely accepted as the optimal treatment for carcinoma in situ and high grade superficial transitional cell carcinoma. However, controversy remains regarding the role of maintenance therapy, and its long-term effect on recurrence and progression.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
pubmed-author:BeckT MTM,
pubmed-author:BlumensteinB ABA,
pubmed-author:BrayL CLC,
pubmed-author:CrawfordE DED,
pubmed-author:CrissmanJ DJD,
pubmed-author:GottesmanJ EJE,
pubmed-author:GrossmanH BHB,
pubmed-author:LammD LDL,
pubmed-author:LeimertJ TJT,
pubmed-author:LoweB ABA,
pubmed-author:MontieJ EJE,
pubmed-author:SarosdyM FMF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
163
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1124-9
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10737480-Adjuvants, Immunologic,
pubmed-meshheading:10737480-Aged,
pubmed-meshheading:10737480-BCG Vaccine,
pubmed-meshheading:10737480-Carcinoma, Transitional Cell,
pubmed-meshheading:10737480-Carcinoma in Situ,
pubmed-meshheading:10737480-Female,
pubmed-meshheading:10737480-Humans,
pubmed-meshheading:10737480-Immunotherapy,
pubmed-meshheading:10737480-Male,
pubmed-meshheading:10737480-Middle Aged,
pubmed-meshheading:10737480-Neoplasm Recurrence, Local,
pubmed-meshheading:10737480-Neoplasms, Multiple Primary,
pubmed-meshheading:10737480-Urinary Bladder Neoplasms
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
|
|
pubmed:affiliation |
West Virginia University Medical Center, Morgantown, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
